European Journal of Haematology, 1600-0609

Journal

More filtering options
  1. 2019
  2. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients

    Rolf Ljung, Auerswald, G., Benson, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Lambert, T., Morfini, M., Zupančić-Šalek, S. & Santagostino, E., 2019 Feb, In : European Journal of Haematology. 102, 2, p. 111-122

    Research output: Contribution to journalReview article

  3. 2018
  4. Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival

    Ingemar Turesson, Bjorkholm, M., Blimark, C. H., Kristinsson, S., Velez, R. & Landgren, O., 2018 Aug 1, In : European Journal of Haematology. 101, 2, p. 237-244 8 p.

    Research output: Contribution to journalReview article

  5. Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort study

    Vaht, K., Göransson, M., Carlson, K., Isaksson, C., Lenhoff, S., Sandstedt, A., Uggla, B., Winiarski, J., Ljungman, P., Brune, M. & Andersson, P. O., 2018, In : European Journal of Haematology. 100, 6, p. 613-620

    Research output: Contribution to journalArticle

  6. 2017
  7. Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

    Moreau, P., Dimopoulos, M. A., Richardson, P. G., Siegel, D. S., Cavo, M., Corradini, P., Weisel, K. C., Delforge, M., O'Gorman, P., Song, K., Chen, C., Bahlis, N., Oriol, A., Hansson, M., Kaiser, M., Anttila, P., Raymakers, R., Joao, C., Cook, G., Sternas, L. & 7 othersBiyukov, T., Slaughter, A., Hong, K., Herring, J., Yu, X., Zaki, M. H. & San Miguel, J., 2017 Sep 1, In : European Journal of Haematology. 99, 3, p. 199-206 8 p.

    Research output: Contribution to journalArticle

  8. Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

    Nahi, H., Genell, A., Wålinder, G., Uttervall, K., Gunnar Juliusson, Karin, F., Markus Hansson, Svensson, R., Linder, O., Carlson, K., Björkstrand, B., Kristinsson, S. Y., Mellqvist, U-H., Blimark, C. & Ingemar Turesson, 2017 Sep, In : European Journal of Haematology. 99, 3, p. 216-222

    Research output: Contribution to journalArticle

  9. Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

    Kozlowski, P., Lennmyr, E., Ahlberg, L., Bernell, P., Hulegårdh, E., Karbach, H., Karlsson, K., Tomaszewska-Toporska, B., Åström, M., Hallböök, H. & the Swedish Adult Acute Lymphoblastic Leukemia Group (SVALL), 2017 Aug 1, In : European Journal of Haematology. 99, 2, p. 141-149 9 p.

    Research output: Contribution to journalArticle

  10. Outcome measures for adult and pediatric hemophilia patients with inhibitors

    Hermans, C., Auerswald, G., Benson, G., Dolan, G., Duffy, A., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Lambert, T., Mehdi Osooli & Zupančić Šalek, S., 2017 Aug 1, In : European Journal of Haematology. 99, 2, p. 103-111 9 p.

    Research output: Contribution to journalReview article

  11. Genomewide association study on monoclonal gammopathy of unknown significance (MGUS)

    Hauke Thomsen, Campo, C., Weinhold, N., da Silva Filho, M. I., Pour, L., Gregora, E., Vodicka, P., Vodickova, L., Hoffmann, P., Nöthen, M. M., Jöckel, K-H., Langer, C., Hajek, R., Goldschmidt, H., Kari Hemminki & Asta Försti, 2017 Jul, In : European Journal of Haematology. 99, 1, p. 70-79 10 p.

    Research output: Contribution to journalArticle

  12. The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany

    Berntorp, E., Dargaud, Y., Hart, D. P., Lobet, S., Mancuso, M. E., d'Oiron, R., Perry, D., Pollard, D., van den Berg, M., Blatný, J., Chambost, H., Doria, A. S., Holme, P. A., Kaczmarek, R., Mantovani, L., McLaughlin, P., Nanayakkara, L., Petrini, P., Sannié, T., Laane, E. & 6 othersMaia, R., Dettoraki, A., Farrell, A., Halimeh, S., Raza, S. & Taylor, S., 2017 Jan 1, In : European Journal of Haematology. 98, s85, p. 1-15 15 p.

    Research output: Contribution to journalArticle

  13. Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register

    Söderlund, S., Dahlén, T., Sandin, F., Olsson-Strömberg, U., Creignou, M., Dreimane, A., Lübking, A., Markevärn, B., Själander, A., Wadenvik, H., Stenke, L., Johan Richter & Höglund, M., 2017 Jan, In : European Journal of Haematology. 98, 1, p. 57-66

    Research output: Contribution to journalArticle

  14. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing

    Malmberg, E. B. R., Ståhlman, S., Rehammar, A., Samuelsson, T., Alm, S. J., Kristiansson, E., Abrahamsson, J., Garelius, H., Louise Pettersson, Mats Ehinger, Palmqvist, L. & Fogelstrand, L., 2017 Jan, In : European Journal of Haematology. 98, 1, p. 26-37

    Research output: Contribution to journalArticle

  15. Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

    Lj Lazarevic, V., Aldana Rosso, Gunnar Juliusson, Antunovic, P., Derolf, Å. R., Deneberg, S., Möllgård, L., Uggla, B., Wennström, L., Wahlin, A., Höglund, M., Lehmann, S. & Bertil Johansson, 2017, In : European Journal of Haematology. 98, 5, p. 493-500

    Research output: Contribution to journalArticle

  16. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib

    Niklas Landberg, Dreimane, A., Rissler, M., Billström, R. & Helena Ågerstam, 2017, In : European Journal of Haematology. 99, 5, p. 442-448 7 p.

    Research output: Contribution to journalArticle

  17. The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia

    Larfors, G., Sandin, F., Johan Richter, Själander, A., Stenke, L., Lambe, M. & Höglund, M., 2017, In : European Journal of Haematology. 98, 4, p. 398-406 9 p.

    Research output: Contribution to journalArticle

  18. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery

    Miesbach, W. & Erik Berntorp, 2017, In : European Journal of Haematology. 98, 2, p. 121-127

    Research output: Contribution to journalArticle

  19. 2016
  20. Partnering to change the world for people with haemophilia: 6th Haemophilia Global Summit, Prague, Czech Republic, 24–26th September 2015

    Jan Astermark, Hart, D., Lobet, S., Blatný, J., d'Oiron, R., Kenet, G., Dolan, G., Libotte, V. & Hermans, C., 2016 Jul 1, In : European Journal of Haematology. 97, p. 3-23 21 p.

    Research output: Contribution to journalPublished meeting abstract

  21. The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

    Erik Berntorp, Hart, D., Mancuso, M. E., d'Oiron, R., Perry, D., O'Mahony, B., Kaczmarek, R., Crato, M., Pasi, J., Miners, A., Katarina Steen Carlsson, Kitchen, S., Boehlen, F., Giangrande, P., Cebura, E., Uitslager, N., Mehdi Osooli, Janeckova, D., Haldon, R. & Rivolta, G. F., 2016 Jul 1, In : European Journal of Haematology. 97, p. 3-18 16 p.

    Research output: Contribution to journalArticle

  22. Enteric-coated mycophenolate sodium could be an alternative to methotrexate for GVHD prophylaxis.

    Lazarevic, V., 2016, In : European Journal of Haematology. 97, 3, p. 213-214

    Research output: Contribution to journalDebate/Note/Editorial

  23. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.

    Gunnarsson, N., Sandin, F., Höglund, M., Stenke, L., Björkholm, M., Lambe, M., Olsson-Strömberg, U., Johan Richter & Själander, A., 2016, In : European Journal of Haematology. 97, 4, p. 387-392

    Research output: Contribution to journalArticle

  24. 2015
  25. Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies.

    Erik Berntorp, Mauser-Bunschoten, E., Jiménez-Yuste, V. & Spears, J. B., 2015, In : European Journal of Haematology. 95, p. 1-15

    Research output: Contribution to journalReview article

  26. Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

    Hjorth-Hansen, H., Stenke, L., Soderlund, S., Dreimane, A., Hans Ehrencrona, Gedde-Dahl, T., Gjertsen, B. T., Hoglund, M., Koskenvesa, P., Lotfi, K., Majeed, W., Markevarn, B., Ohm, L., Olsson-Stromberg, U., Remes, K., Suominen, M., Simonsson, B., Porkka, K., Mustjoki, S. & Johan Richter, 2015, In : European Journal of Haematology. 94, 3, p. 243-250

    Research output: Contribution to journalArticle

  27. Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.

    Lazarevic, V., Hörstedt, A., Bertil Johansson, Antunovic, P., Billström, R., Derolf, A., Lehmann, S., Möllgård, L., Peterson, S., Stockelberg, D., Uggla, B., Vennström, L., Wahlin, A., Höglund, M. & Gunnar Juliusson, 2015, In : European Journal of Haematology. 94, 5, p. 419-423

    Research output: Contribution to journalArticle

  28. Genetic risk factors for inhibitors in haemophilia A

    Bardi, E. & Jan Astermark, 2015, In : European Journal of Haematology. 94, p. 7-10

    Research output: Contribution to journalReview article

  29. Interaction between VWF and FVIII in treating VWD

    Miesbach, W. & Erik Berntorp, 2015, In : European Journal of Haematology. 95, 5, p. 449-454

    Research output: Contribution to journalArticle

  30. Introduction.

    Erik Berntorp, 2015, In : European Journal of Haematology. 94, p. 1-1

    Research output: Contribution to journalDebate/Note/Editorial

  31. Non-genetic risk factors and their influence on the management of patients in the clinic

    Alvarez, T., Soto, I. & Jan Astermark, 2015, In : European Journal of Haematology. 94, p. 2-6

    Research output: Contribution to journalReview article

  32. One-stage vs. chromogenic assays in haemophilia A

    Potgieter, J. J., Damgaard, M. & Andreas Hillarp, 2015, In : European Journal of Haematology. 94, p. 38-44

    Research output: Contribution to journalReview article

  33. Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events

    de Raucourt, E., Roussel-Robert, V. & Eva Zetterberg, 2015, In : European Journal of Haematology. 94, p. 23-29

    Research output: Contribution to journalReview article

  34. Strategies for reducing inhibitor formation in severe haemophilia

    Tunstall, O. & Jan Astermark, 2015, In : European Journal of Haematology. 94, p. 45-50

    Research output: Contribution to journalReview article

  35. Switching treatments in haemophilia: is there a risk of inhibitor development?

    Santagostino, E., Auerswald, G., Benson, G., Dolan, G., Jimenez-Yuste, V., Lambert, T., Rolf Ljung, Morfini, M., Remor, E. & Salek, S. Z., 2015, In : European Journal of Haematology. 94, 4, p. 284-289

    Research output: Contribution to journalReview article

  36. The ageing patient with haemophilia

    Canaro, M., Goranova-Marinova, V. & Erik Berntorp, 2015, In : European Journal of Haematology. 94, p. 17-22

    Research output: Contribution to journalReview article

  37. Various regimens for prophylactic treatment of patients with haemophilia

    Schwarz, R., Rolf Ljung & Ulf Tedgård, 2015, In : European Journal of Haematology. 94, p. 11-16

    Research output: Contribution to journalReview article

  38. 2014
  39. Angiogenesis is increased in advanced haemophilic joint disease and characterized by normal pericyte coverage.

    Eva Zetterberg, Palmblad, J., Wallensten, R., Morfini, M., Melchiorre, D. & Holmström, E. M., 2014, In : European Journal of Haematology. 92, 3, p. 256-262

    Research output: Contribution to journalArticle

  40. High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

    Kozlowski, P., Astrom, M., Ahlberg, L., Bernell, P., Hulegardh, E., Hagglund, H., Karlsson, K., Markuszewska-Kuczymska, A., Tomaszewska-Toporska, B., Smedmyr, B., Amini, R-M. & Hallbook, H., 2014, In : European Journal of Haematology. 92, 5, p. 377-381

    Research output: Contribution to journalArticle

  41. Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review

    Laros-van Gorkom, B. A. P., Falaise, C. & Jan Astermark, 2014, In : European Journal of Haematology. 93, p. 26-38

    Research output: Contribution to journalReview article

  42. Methods for individualising factor VIII dosing in prophylaxis

    Ar, M. C., Vaide, I., Erik Berntorp & Bjorkman, S., 2014, In : European Journal of Haematology. 93, p. 16-20

    Research output: Contribution to journalReview article

  43. On-demand treatment in persons with severe haemophilia

    Trakymiene, S. S. & Katarina Steen Carlsson, 2014, In : European Journal of Haematology. 93, p. 39-47

    Research output: Contribution to journalReview article

  44. Outcome measures in haemophilia: a systematic review

    Boehlen, F., Graf, L. & Erik Berntorp, 2014, In : European Journal of Haematology. 93, p. 2-15

    Research output: Contribution to journalReview article

  45. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

    Giagounidis, A., Mufti, G. J., Mittelman, M., Sanz, G., Platzbecker, U., Muus, P., Selleslag, D., Beyne-Rauzy, O., te Boekhorst, P., del Canizo, C., Guerci-Bresler, A., Nilsson, L., Luebbert, M., Quesnel, B., Ganser, A., Bowen, D., Schlegelberger, B., Goehring, G., Fu, T., Benettaib, B. & 2 othersHellstrom-Lindberg, E. & Fenaux, P., 2014, In : European Journal of Haematology. 93, 5, p. 429-438

    Research output: Contribution to journalArticle

  46. Perinatal aspects of haemophilia

    Economou, M., Banov, L. & Rolf Ljung, 2014, In : European Journal of Haematology. 93, p. 21-25

    Research output: Contribution to journalReview article

  47. 2013
  48. Outcome of poor response paediatric AML using early SCT

    Wareham, N. E., Heilmann, C., Abrahamsson, J., Forestier, E., Gustafsson, B., Ha, S-Y., Heldrup, J., Jahnukainen, K., Jonsson, O. G., Lausen, B., Palle, J., Zeller, B. & Hasle, H., 2013, In : European Journal of Haematology. 90, 3, p. 187-194

    Research output: Contribution to journalArticle

  49. 2012
  50. Angptl4 maintains in vivo repopulation capacity of CD34(+) human cord blood cells.

    Blank Savukinas, U., Ehrnström, B., Heinz, N., Nilsson, E. C., Brun, A., Baum, C., Schiedlmeier, B. & Stefan Karlsson, 2012, In : European Journal of Haematology. 89, 3, p. 198-205

    Research output: Contribution to journalArticle

  51. High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy

    Riihijarvi, S., Nurmi, H., Holte, H., Bjorkholm, M., Fluge, O., Pedersen, L. M., Fjordén, K., Mats Jerkeman, Mikael Eriksson & Leppa, S., 2012, In : European Journal of Haematology. 89, 5, p. 395-402

    Research output: Contribution to journalArticle

  52. Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.

    Benson, G., Auerswald, G., Elezović, I., Lambert, T., Rolf Ljung, Morfini, M., Remor, E. & Salek, S. Z., 2012, In : European Journal of Haematology. 88, 5, p. 371-379

    Research output: Contribution to journalArticle

  53. 2011
  54. Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy

    Riihijarvi, S., Taskinen, M., Mats Jerkeman & Leppa, S., 2011, In : European Journal of Haematology. 86, 2, p. 124-128

    Research output: Contribution to journalArticle

  55. Quality of life, physical function and MRI T2*in elderly low-risk MDS patients treated to a haemoglobin level of >= 120 g/L with darbepoetin alfa +/- filgrastim or erythrocyte transfusions

    Nilsson-Ehle, H., Birgegård, G., Samuelsson Johannesson, J., Antunovic, P., Jan Astermark, Garelius, H., Engström, L., Kjeldsen, L., Nilsson, L., Olsson, A., Skov-Holm, M., Wallvik, J., Gulbrandsen, N. & Hellström-Lindberg, E., 2011, In : European Journal of Haematology. 87, 3, p. 244-252

    Research output: Contribution to journalArticle

  56. When von Willebrand disease comes into age - A matter of change?

    Miesbach, W. & Erik Berntorp, 2011, In : European Journal of Haematology. 86, p. 496-501

    Research output: Contribution to journalArticle

  57. 2010
  58. Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006

    Thorn, I., Forestier, E., Thuresson, B., Wasslavik, C., Malec, M., Li, A., Lindstrom-Eriksson, E., Botling, J., Barbany, G., Jacobsson, S., Olofsson, T., Porwit, A., Sundstrom, C. & Rosenquist, R., 2010, In : European Journal of Haematology. 84, 2, p. 117-127

    Research output: Contribution to journalArticle

  59. MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia

    Willander, K., Ungerback, J., Karlsson, K., Fredrikson, M., Soderkvist, P. & Linderholm, M., 2010, In : European Journal of Haematology. 85, 3, p. 251-256

    Research output: Contribution to journalArticle

  60. 2009
  61. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas

    Nyman, H., Mats Jerkeman, Karjalainen-Lindsberg, M-L., Banham, A. H., Enblad, G. & Leppa, S., 2009, In : European Journal of Haematology. 82, 5, p. 364-372

    Research output: Contribution to journalArticle

  62. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study

    Wahlin, A., Billstrom, R., Bjor, O., Ahlgren, T., Hedenus, M., Hoglund, M., Lindmark, A., Markevarn, B., Nilsson, B., Sallerfors, B. & Brune, M., 2009, In : European Journal of Haematology. 83, 2, p. 99-107

    Research output: Contribution to journalArticle

  63. 2008
  64. U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.

    Hans Ehrencrona, Leuchowius, K-J., Hallböök, H., Nordgren, A., Thörn, I., Thorselius, M., Rosenquist, R., Söderberg, O. & Sundström, C., 2008, In : European Journal of Haematology. 81, 3, p. 218-225

    Research output: Contribution to journalArticle

  65. 2007
  66. Serum calcium is an independent predictor of quality of life in multiple myeloma

    Wisloff, F., Kvam, A. K., Hjorth, M. & Lenhoff, S., 2007, In : European Journal of Haematology. 78, 1, p. 29-34

    Research output: Contribution to journalArticle

  67. Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.

    Linderoth, J., Mats Ehinger, Åkerman, M., Cavallin-Ståhl, E., Enblad, G., Erlanson, M. & Mats Jerkeman, 2007, In : European Journal of Haematology. 79, 2, p. 146-149

    Research output: Contribution to journalArticle

  68. 2006
  69. Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia.

    Karrman, K., Anna Andersson, Björgvinsdottir, H., Strömbeck, B., Lassen, C., Olofsson, T., Nguyen-Khac, F., Berger, R., Bernard, O., Thoas Fioretos & Bertil Johansson, 2006, In : European Journal of Haematology. 77, 1, p. 27-34

    Research output: Contribution to journalArticle

  70. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells

    Mylin, A. K., Rasmussen, T., Johansen, J. S., Knudsen, L. M., Norgaard, P. H., Lenhoff, S., Dahl, I. M. S. & Johnsen, H. E., 2006, In : European Journal of Haematology. 77, 5, p. 416-424

    Research output: Contribution to journalArticle

  71. 2005
  72. Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome.

    Ekberg, J., Wigerup, C., Jalili, S., Johan Richter, Anagnostaki, L., Landberg, G. & Persson, J. L., 2005, In : European Journal of Haematology. 75, 2, p. 106-115

    Research output: Contribution to journalArticle

  73. Management of patients with polycythaemia vera: results of a survey among Swedish haematologists

    Andreasson, B., Lofvenberg, E. & Westin, J., 2005, In : European Journal of Haematology. 74, 6, p. 489-495

    Research output: Contribution to journalArticle

  74. Nordic Myeloma Study Group, the first 15 years: Scientific collaboration and improvement of patient care

    Hippe, E., Westin, J. & Wisloff, F., 2005, In : European Journal of Haematology. 74, 3, p. 185-193

    Research output: Contribution to journalReview article

  75. Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes

    Wisloff, F., Gulbrandsen, N., Hjorth, M., Lenhoff, S. & Fayers, P., 2005, In : European Journal of Haematology. 75, 4, p. 293-298

    Research output: Contribution to journalArticle

  76. 2004
  77. 2003
  78. Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB

    Glimelius, I., Molin, D., Amini, RM., Gustavsson, A., Glimelius, B. & Enblad, G., 2003, In : European Journal of Haematology. 71, 5, p. 327-333

    Research output: Contribution to journalArticle

  79. Early and intermediate stage Hodgkin's lymphoma - report from the Swedish National Care Programme.

    Molin, D., Enblad, G., Gustavsson, A., Ekman, T., Erlanson, M., Haapaniemi, E. & Glimelius, B., 2003, In : European Journal of Haematology. 70, 3, p. 172-180

    Research output: Contribution to journalArticle

  80. Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins.

    Rondin Lindberg, S., Olsson, A., Persson, A-M. & Inge Olsson, 2003, In : European Journal of Haematology. 71, 6, p. 439-447

    Research output: Contribution to journalArticle

  81. Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant

    Andersen, NS., Pedersen, L., Elonen, E., Johnson, A., Kolstad, A., Franssila, K., Langholm, R., Ralfkiaer, E., Åkerman, M., Eriksson, M., Kuittinen, O. & Geisler, CH., 2003, In : European Journal of Haematology. 71, 2, p. 73-80

    Research output: Contribution to journalArticle

  82. 2002
  83. A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma

    Amini, RM., Glimelius, B., Gustavsson, A., Ekman, T., Erlanson, M., Haapaniemi, E. & Enblad, G., 2002, In : European Journal of Haematology. 68, 4, p. 225-232

    Research output: Contribution to journalArticle

  84. 2001
  85. Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping

    Nordgren, A., Farnebo, F., Bertil Johansson, Holmgren, G., Forestier, E., Larsson, C., Söderhäll, S., Nordenskjöld, M. & Blennow, E., 2001, In : European Journal of Haematology. 66, 5, p. 297-304

    Research output: Contribution to journalArticle

  86. 2000
  87. Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias

    Andreasson, P., Mattias Höglund, Békássy, A., Garwicz, S., Heldrup, J., Felix Mitelman & Bertil Johansson, 2000, In : European Journal of Haematology. 65, 1, p. 40-51

    Research output: Contribution to journalArticle

  88. 1999
  89. A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender

    Mauritzson, N., Johansson, B., Maria Albin, Billstrom, R., Ahlgren, T., Mikoczy, Z., Nilsson, P-G., Hagmar, L. & Felix Mitelman, 1999, In : European Journal of Haematology. 62, 2, p. 95-102

    Research output: Contribution to journalArticle

  90. Prognostic implications of cytogenetic aberrations in diffuse large B-cell lymphomas

    Mats Jerkeman, Bertil Johansson, Åkerman, M., Cavallin-Ståhl, E., Ulf Kristoffersson & Felix Mitelman, 1999, In : European Journal of Haematology. 62, 3, p. 184-190

    Research output: Contribution to journalArticle

  91. 1997
  92. Poor survival in t(8;21) (q22;q22)-associated acute myeloid leukaemia with leukocytosis

    Billstrom, R., Bertil Johansson, Thoas Fioretos, Garwicz, S., Malm, C., Zettervall, O. & Felix Mitelman, 1997, In : European Journal of Haematology. 59, 1, p. 47-52

    Research output: Contribution to journalArticle

  93. Successful treatment of syndrome of inappropriate antidiuretic secretion (SIADH) in 2 patients with CNS involvement of chronic lymphocytic leukaemia

    Hagberg, H., Lannemyr, O., Stefan Acosta, Birgegard, G. & Hagberg, H., 1997, In : European Journal of Haematology. 58, 3, p. 207-208

    Research output: Contribution to journalArticle

  94. Ultrastructural localization of Charcot-Leyden crystal protein in human eosinophils and basophils

    Calafat, J., Janssen, H., Knol, E. F., Weller, P. F. & Arne Egesten, 1997, In : European Journal of Haematology. 58, 1, p. 56-66

    Research output: Contribution to journalArticle

  95. 1996
  96. Recurrent mutation Asn45-->Ser of glycoprotein IX in Bernard-Soulier syndrome

    Donnér, M., D Karpman, A C Kristoffersson & Winqvist, I., 1996 Aug, In : European Journal of Haematology. 57, 2, p. 178-9 2 p.

    Research output: Contribution to journalLetter

  97. 1995
  98. Inversions of the factor VIII gene in Swedish patients with severe haemophilia A

    R. Ljung & Sjörin, E., 1995, In : European Journal of Haematology. 54, 5, p. 310-313

    Research output: Contribution to journalArticle

  99. 1994
  100. Haemoglobin Koln as de novo mutations in Sweden: Diagnosis by PCR and specific enzymatic cleavage

    Landin, B., Frostad, B., Brune, M. & R. Ljung, 1994, In : European Journal of Haematology. 52, 3, p. 156-161 6 p.

    Research output: Contribution to journalArticle

  101. 1992
  102. Antenatal diagnosis of haemophilia B by amplification and electrophoresis of an exon fragment with a short deletion

    R. Ljung, Green, P., Sjörin, E., Giannelli, F. & Nilsson, I. M., 1992, In : European Journal of Haematology. 49, 4, p. 215-218 4 p.

    Research output: Contribution to journalArticle

  103. Origin of mutation in sporadic cases of haemophilia-B

    Kling, S., R. Ljung, Sjörin, E., Montandon, J., Green, P., Giannelli, F. & Nilsson, I. M., 1992, In : European Journal of Haematology. 48, 3, p. 142-145

    Research output: Contribution to journalArticle

  104. 1991
  105. Moderate haemophilia B in a female carrier caused by preferential inactivation of the paternal X chromosome

    Kling, S., Coffey, A. J., R. Ljung, Sjörin, E., Nilsson, I. M., L. Holmberg & Giannelli, F., 1991, In : European Journal of Haematology. 47, 4, p. 257-261

    Research output: Contribution to journalArticle

  106. 1990
  107. Deletion of 14q in non‐Hodgkin's lymphoma

    Ulf Kristoffersson, Heim, S., Johnsson, A., Nils Mandahl, Hakan Olsson, Åkerman, M. & Felix Mitelman, 1990 Jan 1, In : European Journal of Haematology. 44, 4, p. 261-264 4 p.

    Research output: Contribution to journalArticle

  108. Heat production rate in blood lymphocytes as a prognostic factor in non‐Hodgkin's lymphoma

    Monti, M., Brandt, L., Ikomi‐Kumm, J. & H. Olsson, 1990 Jan 1, In : European Journal of Haematology. 45, 5, p. 250-254

    Research output: Contribution to journalArticle

  109. Bone marrow karyotypes in 94 children with acute leukemia

    Heim, S., Békássy, A., Garwicz, S., Heldrup, J., Ulf Kristoffersson, Nils Mandahl, Thomas Wiebe & Felix Mitelman, 1990, In : European Journal of Haematology. 44, 4, p. 227-233

    Research output: Contribution to journalArticle

  110. 1989
  111. 1987
  112. 1986
  113. Microcalorimetric investigation of cell metabolism in tumour cells from patients with non‐Hodgkin lymphoma (NHL)

    Monti, M., Brandt, L., Ikomi‐Kumm, J. & H. Olsson, 1986 Jan 1, In : Scandinavian Journal of Haematology. 36, 4, p. 353-357

    Research output: Contribution to journalArticle

Previous 1 2 Next